The Unusual Machines, Inc. (UMAC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Unusual Machines is a Nevada corporation with common stock listed on NYSE American under the symbol UMAC, and it files current and periodic reports that describe its operations, governance, and financial position.
Among the most relevant documents for investors are the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, segment information, and management’s discussion of results. For example, a shareholder letter furnished with a Form 8‑K references a Form 10‑Q filing and provides context on revenue trends, margins, cash position, and capital raises, all of which are detailed in the underlying report.
Unusual Machines also files numerous Current Reports on Form 8-K that disclose material events. Recent 8‑Ks describe items such as purchase orders from Performance Drone Works, a strategic supplier agreement with Dynamic Aerospace Systems, an adjournment and subsequent results of the 2025 Annual Meeting of Stockholders, the lease of a 25,000-square-foot Orlando facility for manufacturing and fulfillment, and a $25 million investment into XTI Aerospace via Series 10 Convertible Preferred Stock. Other 8‑Ks furnish investor presentations and shareholder letters, giving additional insight into strategy and operations.
Proxy materials, including the Definitive Proxy Statement on Schedule 14A, outline board elections, annual meeting procedures, and governance matters. These documents detail how directors are chosen, how stockholders can vote (including virtual meeting logistics), and what proposals are on the ballot.
On Stock Titan, Unusual Machines filings are updated in near real time from EDGAR, and AI-powered summaries help explain the key points of lengthy reports such as 10‑K and 10‑Q filings. Users can quickly understand topics like capital structure changes, lease commitments for new facilities, strategic investments, and outcomes of shareholder votes without reading every page. The filings page also makes it easier to monitor Form 4 insider transaction reports and other ownership-related filings when they are available, giving a clearer view of how executives and major holders interact with UMAC stock.
By using this page, investors can efficiently review Unusual Machines’ regulatory history, from financial performance and manufacturing expansion to governance decisions and strategic partnerships, with AI tools that highlight the most important disclosures in each filing.
Unusual Machines, Inc. (UMAC) CEO Allan Evans reported a cashless exercise of stock warrants and related share withholding. On 12/29/2025, he exercised 65,789 common stock purchase warrants at an exercise price of $1.99 per share, coded as transaction type "M". The exercise was carried out on a cashless basis, so the issuer withheld 11,087 warrant shares to cover the exercise price and issued the remaining 54,702 shares of common stock to Evans.
Following these transactions, Evans directly held 165,491 shares of common stock and indirectly held 1,203,650 shares through 8 Consulting LLC, over which he has sole voting and dispositive control. The company’s board of directors approved the cashless exercise, and it was treated as exempt from Section 16(b) under Rule 16b-3.
Unusual Machines, Inc. reported that it received a purchase order from Performance Drone Works (PDW) valued at $3.75 million. The order is intended to support the scaling of PDW’s AM-FPV program and investment in America’s small unmanned aircraft systems (sUAS) supply base. The company shared this information through a press release, which is included as an exhibit to the report but is furnished rather than filed, meaning it is not subject to certain Exchange Act liability provisions.
Unusual Machines, Inc. reported the results of its 2025 Annual Meeting of stockholders held on December 19, 2025. Stockholders voted on the election of five directors for one-year terms expiring at the next annual meeting and on a potential adjournment proposal if additional proxy solicitation were needed.
All five director nominees were elected. Dr. Allan Evans received 11,144,230 votes for and 101,184 abstentions; Cristina A. Colón received 10,900,065 votes for and 345,349 abstentions; Robert Lowry received 11,134,723 votes for and 110,691 abstentions; Sanford Rich received 11,142,091 votes for and 103,323 abstentions; and Jeffrey Thompson received 10,624,575 votes for and 620,839 abstentions. Because there were sufficient votes to approve the director elections, the adjournment proposal did not need to be considered and was deemed moot.
Unusual Machines, Inc. disclosed that on December 17, 2025 it uploaded a new investor presentation to its website and furnished it as Exhibit 99.1 to a current report under Item 7.01, Regulation FD Disclosure. The company notes that the information in Item 7.01, including Exhibit 99.1, is being furnished rather than filed, is not subject to liability under Section 18 of the Exchange Act, and is not incorporated by reference into other Securities Act or Exchange Act filings.
Unusual Machines, Inc. disclosed an insider stock sale by its Chief Operating Officer, Andrew Camden. On 12/12/2025, Camden sold 50,000 shares of Unusual Machines common stock in open-market transactions at a weighted average price of $10.3152 per share, with individual trades ranging from $9.935 to 10.80.
Following this sale, Camden directly beneficially owns 256,000 shares of Unusual Machines common stock, as reported on this Form 4, which was filed for a single reporting person.
Unusual Machines, Inc.'s chief financial officer Brian Hoff sold 75,000 shares of common stock on December 12, 2025 at a weighted average price of $10.3143 per share. The shares were sold in multiple transactions within a price range from $9.94 to $10.805.
After this sale, Hoff beneficially owned 415,475 shares of Unusual Machines common stock in direct ownership. He has undertaken to provide, upon request, full details of the number of shares sold at each separate price within this range.
UMAC insider Brian Joseph Hoff has filed a notice of proposed sale of company common stock under Rule 144. The filing indicates an intention to sell 75,000 shares of common stock through broker Maxim Group on the NYSE American, with an aggregate market value of $816,000. The filing notes that 37,565,276 shares of the issuer’s common stock were outstanding.
The shares to be sold come from 100,000 common shares acquired on 02/03/2025 as restricted stock units from the issuer, designated as compensation, with a payment date of 12/12/2025. The insider also reported a prior sale during the past three months of 8,750 common shares on 11/20/2025 for gross proceeds of $79,625.
UMAC insider Andrew Ross Camden has filed a notice of proposed sale under Rule 144 to sell 50,000 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $544,000. The filing reports that 37,565,276 shares of the issuer’s common stock are outstanding, providing context for the size of the planned sale.
The shares to be sold come from 100,000 restricted stock units acquired from the issuer on 02/03/2025 as compensation, with the payment date listed as 12/12/2025. The notice also discloses that Camden sold 8,750 common shares on 11/20/2025 for gross proceeds of $79,625 during the past three months, as required by Rule 144 aggregation rules.
Unusual Machines, Inc. filed a current report to let investors know it has entered into a strategic supplier agreement with BrooQLy, Inc., which does business as Dynamic Aerospace Systems. Dynamic Aerospace Systems develops next generation unmanned aerial systems for commercial and defense uses, so this relationship is aimed at supporting Unusual Machines’ position in the drone and aerospace market. Details of the agreement itself are provided in a press release dated December 8, 2025, which is included as an exhibit to the report.
Unusual Machines, Inc. reported that its Annual Meeting of Stockholders, which began on December 1, 2025, has been adjourned until December 19, 2025, at 1:00 p.m. ET. The company is using the additional time to solicit more proxy votes so that a quorum can be reached and stockholders can vote on the election of five directors to serve one-year terms until the next annual meeting. This update was communicated through a press release furnished as an exhibit to the current report.